Identifying the Need for Good Practices in Health Technology Assessment

Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

Finn Børlum Kristensen, Don Husereau, Mirjana Huić, Michael Drummond, Marc L Berger, Kenneth Bond, Federico Augustovski, Andrew Booth, John F P Bridges, Jeremy Grimshaw, Maarten J IJzerman, Egon Jonsson, Daniel A Ollendorf, Alric Rüther, Uwe Siebert, Jitendar Sharma, Allan Wailoo

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers.

Original languageEnglish
JournalValue in Health
Volume22
Issue number1
Pages (from-to)13-20
ISSN1098-3015
DOIs
Publication statusPublished - Jan 2019

Fingerprint

Capacity Building
Research Personnel
Guidelines
Delivery of Health Care
Education
Equipment and Supplies
Health
Pharmaceutical Preparations
Population
Recognition (Psychology)

Keywords

  • Benchmarking/economics
  • Consensus
  • Evidence-Based Medicine/standards
  • Humans
  • Policy Making
  • Stakeholder Participation
  • Technology Assessment, Biomedical/economics

Cite this

Kristensen, Finn Børlum ; Husereau, Don ; Huić, Mirjana ; Drummond, Michael ; Berger, Marc L ; Bond, Kenneth ; Augustovski, Federico ; Booth, Andrew ; Bridges, John F P ; Grimshaw, Jeremy ; IJzerman, Maarten J ; Jonsson, Egon ; Ollendorf, Daniel A ; Rüther, Alric ; Siebert, Uwe ; Sharma, Jitendar ; Wailoo, Allan. / Identifying the Need for Good Practices in Health Technology Assessment : Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. In: Value in Health. 2019 ; Vol. 22, No. 1. pp. 13-20.
@article{261b9c6c819c47c28273bfd4e9c38f11,
title = "Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA",
abstract = "The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers.",
keywords = "Benchmarking/economics, Consensus, Evidence-Based Medicine/standards, Humans, Policy Making, Stakeholder Participation, Technology Assessment, Biomedical/economics",
author = "Kristensen, {Finn B{\o}rlum} and Don Husereau and Mirjana Huić and Michael Drummond and Berger, {Marc L} and Kenneth Bond and Federico Augustovski and Andrew Booth and Bridges, {John F P} and Jeremy Grimshaw and IJzerman, {Maarten J} and Egon Jonsson and Ollendorf, {Daniel A} and Alric R{\"u}ther and Uwe Siebert and Jitendar Sharma and Allan Wailoo",
note = "Copyright {\circledC} 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.",
year = "2019",
month = "1",
doi = "10.1016/j.jval.2018.08.010",
language = "English",
volume = "22",
pages = "13--20",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",
number = "1",

}

Kristensen, FB, Husereau, D, Huić, M, Drummond, M, Berger, ML, Bond, K, Augustovski, F, Booth, A, Bridges, JFP, Grimshaw, J, IJzerman, MJ, Jonsson, E, Ollendorf, DA, Rüther, A, Siebert, U, Sharma, J & Wailoo, A 2019, 'Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA', Value in Health, vol. 22, no. 1, pp. 13-20. https://doi.org/10.1016/j.jval.2018.08.010

Identifying the Need for Good Practices in Health Technology Assessment : Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. / Kristensen, Finn Børlum; Husereau, Don; Huić, Mirjana; Drummond, Michael; Berger, Marc L; Bond, Kenneth; Augustovski, Federico; Booth, Andrew; Bridges, John F P; Grimshaw, Jeremy; IJzerman, Maarten J; Jonsson, Egon; Ollendorf, Daniel A; Rüther, Alric; Siebert, Uwe; Sharma, Jitendar; Wailoo, Allan.

In: Value in Health, Vol. 22, No. 1, 01.2019, p. 13-20.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Identifying the Need for Good Practices in Health Technology Assessment

T2 - Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

AU - Kristensen, Finn Børlum

AU - Husereau, Don

AU - Huić, Mirjana

AU - Drummond, Michael

AU - Berger, Marc L

AU - Bond, Kenneth

AU - Augustovski, Federico

AU - Booth, Andrew

AU - Bridges, John F P

AU - Grimshaw, Jeremy

AU - IJzerman, Maarten J

AU - Jonsson, Egon

AU - Ollendorf, Daniel A

AU - Rüther, Alric

AU - Siebert, Uwe

AU - Sharma, Jitendar

AU - Wailoo, Allan

N1 - Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

PY - 2019/1

Y1 - 2019/1

N2 - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers.

AB - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers.

KW - Benchmarking/economics

KW - Consensus

KW - Evidence-Based Medicine/standards

KW - Humans

KW - Policy Making

KW - Stakeholder Participation

KW - Technology Assessment, Biomedical/economics

U2 - 10.1016/j.jval.2018.08.010

DO - 10.1016/j.jval.2018.08.010

M3 - Journal article

VL - 22

SP - 13

EP - 20

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 1

ER -